Somewhere in the United States this week, a family is arranging for a dying parent to come home. They have spoken to a hospice coordinator, filled out intake forms, and been told that Medicare will cover the care. What they have not been told is that if the provider they need is new to Medicare enrollment — licensed, credentialed, waiting for approval — that provider is now frozen out. The Department of Health and Human Services has imposed a six-month moratorium on all new Medicare enrollments for home health care and hospice providers, effective immediately, according to The Hill. The administration's stated rationale is fraud prevention.
The stated rationale and the mechanism are not the same thing. Fraud prevention, as a policy goal, targets bad actors. This moratorium targets access. It does not suspend the licenses of fraudulent providers already enrolled. It does not accelerate audits of existing billing irregularities. It stops new providers — including entirely legitimate ones — from entering the Medicare system at all. The people who cannot wait six months for that to change are patients in the last chapter of their lives.
The HHS moratorium prevents any new home health or hospice provider from enrolling in Medicare for six months. Providers already enrolled are unaffected. New providers — including those serving rural or underserved areas with no existing coverage — cannot accept Medicare patients during this period, regardless of their licensing status or compliance record.
Home health care and hospice are not interchangeable with hospital care. They exist precisely because Medicare recognized, decades ago, that patients recovering from surgery, managing chronic illness, or approaching death are better served — and often better off financially for the system — when care comes to them. Hospice in particular is designed for patients whose doctors have determined that curative treatment is no longer the goal. These are not patients who can be told to wait. Their care windows are measured in weeks.
The structural problem with this freeze is not that the administration wants to fight Medicare fraud. Fraud in home health and hospice is real and well-documented. The Centers for Medicare and Medicaid Services has flagged it repeatedly. Billing for services never rendered, enrolling patients who don't qualify, kickback arrangements between providers and referral sources — these are genuine problems that cost the program billions annually. No serious observer disputes that.
What the moratorium does not do is touch any of that. Fraudulent providers already inside the system continue operating. The freeze applies exclusively at the point of entry, which means it functions less like a fraud crackdown and more like a gate that locks out everyone — honest and dishonest alike — who hasn't already passed through it. Policy critics have long noted that enrollment moratoriums of this kind tend to calcify existing market conditions rather than clean them up: incumbents stay in, new competition stays out, and access gaps in underserved areas widen.
That access dimension deserves more attention than it is getting. Home health and hospice coverage is not uniform across the country. Rural areas, low-income urban neighborhoods, and communities of color are systematically underserved by these providers. The reason is straightforward: Medicare reimbursement rates make thin margins thinner in areas where operational costs are higher and patient density is lower. New providers entering those markets are often doing so because an existing gap exists. A six-month enrollment freeze does not freeze the gap — it extends it.
This is also not the administration's first use of blunt-instrument policy to address a problem that would respond better to targeted enforcement. The pattern is worth naming. Across multiple agencies, the current administration has reached for sweeping suspensions, moratoriums, and enrollment freezes in contexts where the stated problem — fraud, abuse, inefficiency — is real but the remedy is deliberately broad. The breadth is not incidental. A targeted crackdown requires building a case, marshaling evidence, and making specific determinations about specific actors. A moratorium requires a press release. The same pattern of using broad administrative action to substitute for specific accountability has appeared across the federal government in recent months.
There is also a financial logic here that runs beneath the fraud narrative. Hospice and home health care are expensive Medicare line items. A freeze on new provider enrollment is, functionally, a constraint on the expansion of those line items. Whether that constraint was designed with budget reduction in mind or simply has that effect, the outcome is the same: fewer providers means fewer covered patients means lower Medicare expenditure. That is not fraud prevention. That is rationing, achieved without calling it rationing.
The administration has not disclosed which specific fraud patterns or geographic markets prompted this particular action, nor has it explained why a blanket moratorium was chosen over targeted suspension of providers under active investigation. Government statements attributed the decision to fraud concerns without specifying the evidence base or the enforcement actions that will accompany the freeze. HHS stated the moratorium went into effect immediately — meaning no transition period, no carve-outs for providers mid-enrollment, and no announced appeals mechanism for providers who can demonstrate compliance.
The human cost of that immediacy is not abstract. Hospice care requires a provider willing to accept a patient, a patient who qualifies, and a Medicare enrollment that makes the arrangement financially viable. Remove any one of those three legs and the arrangement collapses. For families in markets where only one or two hospice providers operate — or where a new provider was the only one willing to serve their area — the freeze does not delay access. It eliminates it. This connects to a broader pattern of federal policy decisions that treat access to end-of-life and critical care as an administrative variable rather than a moral floor.
It is worth asking who bears the cost when a hospice provider cannot enroll. Not the provider — they redirect to private pay or simply don't enter the market. Not the administration, which will report the moratorium as a fraud-fighting measure regardless of outcome. The cost lands on the patient and the family: on the person who cannot afford private hospice, who does not have a hospital bed at home, who was counting on a covered provider that is now frozen out of the system that was supposed to serve them.
Congress has largely been absent from this conversation. Medicare enrollment policy sits within executive branch authority over CMS, which means HHS can impose and lift moratoriums without a vote. That is a structural accountability gap. The administration chose the broadest available tool, applied it immediately, and aimed it at the most vulnerable point in the care continuum — the moment when a patient has run out of time for the system to figure itself out. That is not a fraud crackdown. It is a policy that uses the language of enforcement to achieve outcomes enforcement alone could never justify.
When the six months end, HHS will have the option to extend the moratorium, lift it, or convert it into something more permanent. The providers frozen out during that window — and the patients who needed them — will not get those months back. The administration will claim credit for fighting fraud. The audit results, if they come at all, will arrive long after the families have made other arrangements, or no arrangements at all.
